Original Article
Safety and effectiveness of bDMARDs during pregnancy in patients with rheumatic diseases: Real-world data from the BIOBADASER registry
Seguridad y efectividad de los FAME biológicos durante el embarazo en pacientes con enfermedades reumáticas: datos del mundo real procedentes del registro BIOBADASER
Cristina Membrive-Jiméneza,
, Carlos Sánchez-Piedrab, Olga Martínez-Gonzálezc, Javier García-Gonzálezd, Lorena Expósito-Péreze, Cristina Bohórquez-Herasf, Cristina Campos-Fernándezg, Fernando Sanchez-Alonsob, Rafael Cáliz-Cáliza, Isabel Castrejón-Fernándezh
Corresponding author
a Rheumatology Department, Hospital Universitario Virgen de las Nieves, Granada, Spain
b Health Technology Assessment Agency (AETS), Instituto de Salud Carlos III, Madrid, Spain
c Rheumatology Department, Hospital Universitario de Salamanca, Salamanca, Spain
d Rheumatology Department, Hospital Universitario Doce de Octubre, Huesca, Spain
e Rheumatology Department, Hospital Universitario de Canarias, La Laguna, Spain
f Rheumatology Department, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain
g Rheumatology Department, Hospital General Universitario de Valencia, Valencia, Spain
h Rheumatology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
Read
896
Timeswas read the article
361
Total PDF
535
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 74 | 25 | 99 |
| 2024 November | 73 | 58 | 131 |
| 2024 October | 45 | 45 | 90 |
| 2024 September | 53 | 31 | 84 |
| 2024 August | 85 | 72 | 157 |
| 2024 July | 88 | 37 | 125 |
| 2024 June | 63 | 48 | 111 |
| 2024 May | 54 | 45 | 99 |
